ANI Pharmaceuticals Inc (ANIP) Insider Trading
- $2,005,711.60
- $143,539,901.93
- March 5, 2026
- Muthusamy Shanmugam
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| June 22, 2023 | SVP | 20,000 | $51.32 | Sell | $1,026,400.00 | |
| June 22, 2023 | COO | 13,500 | $51.38 | Sell | $693,630.00 | |
| June 20, 2023 | COO | 14,657 | $51.93 | Sell | $761,138.01 | |
| Aug. 15, 2022 | SVP | 5,172 | $37.79 | Sell | $195,449.88 | |
| Aug. 12, 2022 | SVP | 12,894 | $37.04 | Sell | $477,593.76 | |
| March 21, 2022 | CEO | 7,224 | $27.69 | Buy | $200,032.56 | |
| March 21, 2022 | Director | 5,000 | $27.76 | Buy | $138,800.00 | |
| March 17, 2022 | COO | 5,000 | $27.65 | Buy | $138,250.00 | |
| Dec. 20, 2021 | Director | 1,072 | $46.47 | Buy | $49,815.84 | |
| Dec. 6, 2021 | Director | 2,500 | $39.38 | Buy | $98,450.00 | |
| March 15, 2021 | Director | 4,000 | $32.89 | Buy | $131,560.00 | |
| Nov. 9, 2020 | Director | 5,000 | $25.96 | Buy | $129,800.00 | |
| Aug. 10, 2020 | CEO | 10,000 | $30.78 | Buy | $307,800.00 | |
| March 3, 2020 | Director | 2,000 | $45.18 | Buy | $90,360.00 | |
| Aug. 20, 2019 | Major Shareholder | 7,579 | $68.21 | Sell | $516,963.59 | |
| Aug. 15, 2019 | Major Shareholder | 9,315 | $69.34 | Sell | $645,902.10 | |
| Aug. 13, 2019 | Major Shareholder | 61,697 | $71.64 | Sell | $4,419,973.08 | |
| Aug. 9, 2019 | Major Shareholder | 19,860 | $71.70 | Sell | $1,423,962.00 | |
| May 24, 2019 | Director | 1,445 | $68.76 | Buy | $99,358.20 | |
| May 17, 2019 | SVP | 8,907 | $70.67 | Sell | $629,457.69 | |
| May 15, 2019 | Insider | 30,000 | $70.07 | Sell | $2,102,100.00 | |
| May 15, 2019 | Director | 2,500 | $69.30 | Buy | $173,250.00 | |
| May 13, 2019 | CEO | 9,595 | $71.10 | Sell | $682,204.50 | |
| May 13, 2019 | SVP | 2,409 | $71.13 | Sell | $171,352.17 | |
| March 19, 2019 | Insider | 27,625 | $63.53 | Sell | $1,755,016.25 | |
| March 13, 2019 | SVP | 4,651 | $64.43 | Sell | $299,663.93 | |
| May 16, 2018 | Director | 38,236 | $62.33 | Sell | $2,383,249.88 | |
| May 10, 2018 | Director | 62,431 | $62.07 | Sell | $3,875,092.17 | |
| April 18, 2018 | Director | 33,200 | $62.09 | Sell | $2,061,388.00 | |
| March 19, 2018 | Director | 7,215 | $60.85 | Sell | $439,032.75 | |
| March 14, 2018 | Director | 27,964 | $62.24 | Sell | $1,740,479.36 | |
| March 14, 2018 | Insider | 40,000 | $61.83 | Sell | $2,473,200.00 | |
| March 12, 2018 | Director | 64,221 | $63.03 | Sell | $4,047,849.63 | |
| March 8, 2018 | Director | 15,391 | $63.08 | Sell | $970,864.28 | |
| March 5, 2018 | SVP | 4,177 | $61.92 | Sell | $258,639.84 | |
| March 1, 2018 | SVP | 28,652 | $61.66 | Sell | $1,766,682.32 | |
| Aug. 22, 2016 | Insider | 37,455 | $66.97 | Sell | $2,508,361.35 | |
| Aug. 8, 2016 | VP | 12,500 | $67.06 | Sell | $838,250.00 | |
| Dec. 18, 2015 | VP | 3,500 | $43.26 | Sell | $151,410.00 | |
| Nov. 12, 2015 | CEO | 2,500 | $40.95 | Buy | $102,375.00 | |
| March 19, 2015 | VP | 15,000 | $66.50 | Sell | $997,500.00 | |
| Sept. 15, 2014 | Director | 3,000 | $27.49 | Buy | $82,470.00 | |
| Sept. 9, 2014 | CEO | 1,000 | $26.50 | Buy | $26,500.00 | |
| June 18, 2014 | VP | 5,000 | $34.28 | Sell | $171,400.00 | |
| May 8, 2014 | Director | 1,381 | $30.02 | Sell | $41,457.62 | |
| May 7, 2014 | Director | 2,000 | $30.38 | Buy | $60,760.00 | |
| March 21, 2014 | Director | 21,767 | $31.42 | Sell | $683,919.14 | |
| March 20, 2014 | major shareholder | 20,922 | $32.12 | Sell | $672,014.64 | |
| March 19, 2014 | Director | 25,358 | $33.68 | Sell | $854,057.44 | |
| March 18, 2014 | major shareholder | 60,540 | $34.07 | Sell | $2,062,597.80 |
Insiders are both buying and selling ANI Pharmaceuticals Inc stock.
The insider traders at ANI Pharmaceuticals Inc are: Muthusamy Shanmugam, Meredith Cook, Chad Gassert, Tracy Marshbanks, James G Marken, Meridian Venture Partners Ii L, Nikhil Lalwani, Krista Davis, Arthur Przybyl, Stephen P Carey, Ori Gutwerg, Patrick D Walsh, Robert W Schrepfer, Christopher Mutz, Thomas Haughey, Ross J Mangano, Antonio R Pera, Jeanne Thoma, Matthew J Leonard, Daniel Raynor, Renee P Tannenbaum, Thomas Andrew Rowland, David Nash, and Ross Mangano
The most active insider trader at ANI Pharmaceuticals Inc is Muthusamy Shanmugam with 36 trades.
Muthusamy Shanmugam has sold the most ANI Pharmaceuticals Inc stock with a total value of $45,394,142.03.
Patrick D Walsh has bought the most ANI Pharmaceuticals Inc stock with a total value of $846,760.00.
The most recent insider trade for ANI Pharmaceuticals Inc was on March 5, 2026.
The single biggest insider buy for ANI Pharmaceuticals Inc was from Patrick D Walsh with a total value of $307,800.00 on Aug. 10, 2020.
The single biggest insider sell for ANI Pharmaceuticals Inc was from Meridian Venture Partners Ii L with a total value of $11,700,000.00 on Aug. 16, 2023.
